We are live on ! Find out more
BCI

Bain Capital Investors Portfolio holdings

AUM $4.82B
1-Year Est. Return 35.43%
This Fund
S&P 500
This Quarter Est. Return
+25.83%
1 Year Est. Return
+35.43%
3 Year Est. Return
+91.12%
5 Year Est. Return
+78.55%
10 Year Est. Return
+1,013.83%
AUM
$4.82B
AUM Growth
+$1.55B
Cap. Flow
+$577M
Cap. Flow %
11.98%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KLRA
Kailera Therapeutics
KLRA
+$577M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 62.9%
2 Consumer Discretionary 31.33%
3 Technology 5.67%
4 Communication Services 0.1%
5 Miscellaneous 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOBS
1
Bobs Discount Furniture
BOBS
$1.8B
$1.51B 31.33%
95,370,751
– –
SGRY icon
2
Surgery Partners
SGRY
$1.89B
$839M 17.42%
49,946,972
– –
AVAH icon
3
Aveanna Healthcare
AVAH
$2.71B
$699M 14.52%
81,600,880
– –
KMTS
4
Kestra Medical Technologies
KMTS
$1.62B
$640M 13.3%
25,172,338
– –
KLRA
5
Kailera Therapeutics
KLRA
$1.45B
$578M 12.01%
+26,255,581
New +$577M
NTNX icon
6
Nutanix
NTNX
$18.4B
$273M 5.67%
5,355,285
– –
WAY
7
Waystar Holding Corp
WAY
$4.74B
$272M 5.65%
13,243,539
– –
ADV icon
8
Advantage Solutions
ADV
$425M
$5M 0.1%
115,600
– –

Similar funds

SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
AG
AlTi Global New York $4.84B AUM 25.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
TI
Truepoint Inc Cincinnati, Ohio $4.79B AUM 16.42% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Bain Capital Investors's Q2 2026 Portfolio in Review

As of Q2 2026, Bain Capital Investors held 8 positions worth $4.82B, up 47% from $3.27B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bain Capital Investors deployed $577M of net new capital in Q2 2026, opening 1 new position. Its largest new stake was Kailera Therapeutics: 26,255,581 shares worth $578M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 59% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bain Capital Investors's largest Q2 2026 buy was Kailera Therapeutics: 26,255,581 shares worth $578M.
  • Bain Capital Investors's ten largest holdings make up 100% of its $4.82B portfolio in Q2 2026.
  • Bain Capital Investors opened 1 new position and closed 0 in Q2 2026.
  • Bain Capital Investors's portfolio value rose 47% quarter-over-quarter to $4.82B.

Based on Bain Capital Investors's 13F filing for Q2 2026, filed 14 Aug 2026.